3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
16
Phase 1
12
Phase 1/2
5
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
20
Thoracic
18
Genitourinary
14
Gastrointestinal
8
Other solid neoplasm
3
Head & Neck
3
CNS
2
Sarcoma
1
Gynecologic
1
Conditions
Sarcoma
1
Interventions
Doxorubicin
40
Radiotherapy
30
Ifosfamide
28
Vincristine
27
Cyclophosphamide
24
Imatinib Mesylate
20
Etoposide
20
Dactinomycin
14
Radiation
13
Filgrastim
11
Temozolomide
9
Sunitinib
9
Trabectedin
8
Methotrexate
8
Specimen Handling
7
Magnetic Resonance Spectroscopy
6
Granulocyte Colony-Stimulating Factor
6
Chemotherapy, Adjuvant
6
pazopanib
5
nilotinib
5
Zoledronic Acid
5
Neoadjuvant Therapy
5
Irinotecan
5
Cisplatin
5
Carboplatin
5
X-Rays
4
Vinorelbine
4
Topotecan
4
Surgical Procedures, Operative
4
Procarbazine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Ipilimumab
×
Sarcoma
×
Clear all
NCT04741438
2023-08-30
RAR-Immune
Centre Leon Berard
Phase 3
Unknown
96 enrolled